who qualifies for semaglutide for Weight Loss? qualifications for semaglutide Semaglutide Dosing

Consult your pharmacist or GP if you have kidney disease, stomach ulcers, or other relevant conditions

Semaglutide crosses the blood-brain barrier and activates these receptors directly

Under the Medicines and Related Substances Act (Act 101 of 1965, as amended), unregistered medicines may not be advertised or sold for therapeutic use in South Africa without authorisation

SELECT trial investigators

"For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory." Lilly is investing in a major phase 3 programme for retatrutide, which it sees as a successor to its fast-growing dual GIP/GLP-1 agonist Zepbound/Mounjaro (tirzepatide) now the top-selling drug worldwide and also as a companion to new oral GLP-1 agonist Foundayo (orforglipron) as it battles for market share with main rival Novo Nordisk